104
Views
1
CrossRef citations to date
0
Altmetric
Editorial

Adherence must always be considered: Is everolimus really ineffective as a treatment for atopic dermatitis?

Pages 317-318 | Received 06 Jul 2009, Accepted 27 Aug 2009, Published online: 02 Dec 2009

References

  • van Velsen SGA, Haeck IM, Bruijnzeel-Koomen CAFM. Severe atopic dermatitis treated with everolimus.
  • Krejci-Manwaring J, Tusa MG, Carroll C, Camacho F, Kaur M, Carr D, Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol. 2007;56:211–6
  • Brown KL, Krejci-Manwaring J, Tusa MG, Camacho F, Fleischer AB Jr, Balkrishnan R, . Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J. 2008;14:13.
  • Feldman SR, Camacho FT, Krejci-Manwaring J, Carroll CL, Balkrishnan R. Adherence to topical therapy increases around the time of office visits. J Am Acad Dermatol. 2007;57:81-3.
  • Ali SM, Brodell RT, Balkrishnan R, Feldman SR. Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol. 2007;143:912-5.
  • Storm A, Andersen SE, Benfeldt E, Serup J. One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol. 2008;59:27-33.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.